The importance of CXCL12/CXCR4 in intraosseous tumor cell dissemination is further underpinned by the observation that inhibition of CXCR4 remobilizes PrCa DTCs back into circulation, thus possibly increasing their vulnerability to anticancer treatment [215,216]. Here, CXCL12 is linked to neoplasm.